{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:06:46Z","timestamp":1787238406251,"version":"build-2736575974"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Multiple myeloma (MM) is the most common malignant monoclonal disease of plasma cells. Aside from classical chemotherapy and glucocorticoids, proteasome inhibitors, immunomodulatory agents and monoclonal antibodies are used in the current treatment scheme of MM. The tumor microenvironment (TME) plays a fundamental role in the development and progression of numerous solid and non-solid cancer entities. In MM, the survival and expansion of malignant plasma cell clones heavily depends on various direct and indirect signaling pathways provided by the surrounding bone marrow (BM) niche. In a number of MM patients, single plasma cell clones lose their BM dependency and are capable to engraft at distant body sites or organs. The resulting condition is defined as an extramedullary myeloma (EMM). EMMs are highly aggressive disease stages linked to a dismal prognosis. Emerging literature demonstrates that the dynamic interactions between the TME and malignant plasma cells affect myeloma dissemination. In this review, we aim to summarize how the cellular and non-cellular BM compartments can promote plasma cells to exit their BM niche and metastasize to distant intra-or extramedullary locations. In addition, we list selected therapy concepts that directly target the TME with the potential to prevent myeloma spread.<\/jats:p>","DOI":"10.3389\/fonc.2022.941437","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T03:55:30Z","timestamp":1656647730000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Molecular Impact of the Tumor Microenvironment on Multiple Myeloma Dissemination and Extramedullary Disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Stefan","family":"Forster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Radpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12790","article-title":"Prevalence of Symptoms in Patients With Multiple Myeloma: A Systematic Review and Meta-Analysis","volume":"97","author":"Ramsenthaler","year":"2016","journal-title":"Eur J Haematol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60493-1","article-title":"Multiple Myeloma","volume":"385","author":"R\u00f6llig","year":"2015","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple Myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat Rev Dis Prim"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group Updated Criteria for the Diagnosis of Multiple Myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0866","article-title":"New Developments in Diagnosis, Prognosis, and Assessment of Response in Multiple Myeloma","volume":"22","author":"Landgren","year":"2016","journal-title":"Clin Cancer Res:  Off J Am Assoc Cancer Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41408-020-00359-2","article-title":"Multiple Myeloma Current Treatment Algorithms","volume":"10","author":"Rajkumar","year":"2020","journal-title":"Blood Cancer J"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4065\/79.7.867","article-title":"Clinical Course of Patients With Relapsed Multiple Myeloma","volume":"79","author":"Kumar","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.9290","article-title":"Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach","volume":"29","author":"Blad\u00e9","year":"2011","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-77633-5_23","article-title":"Circulating Peripheral Blood Plasma Cells in Multiple Myeloma","volume":"182","author":"Witzig","year":"1992","journal-title":"Curr Top Microbiol Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-05-1858","article-title":"Circulating Plasma Cells Detected by Flow Cytometry as a Predictor of Survival in 302 Patients With Newly Diagnosed Multiple Myeloma","volume":"106","author":"Nowakowski","year":"2005","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705982","article-title":"Extramedullary Relapses After Allogeneic non-Myeloablative Stem Cell Transplantation in Multiple Myeloma Patients do Not Negatively Affect Treatment Outcome","volume":"41","author":"Minnema","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.hoc.2007.08.007","article-title":"The Role of the Bone Marrow Microenvironment in the Pathophysiology of Myeloma and its Significance in the Development of More Effective Therapies","volume":"21","author":"Mitsiades","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"key":"B13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1080\/10428190310001597964","article-title":"Myeloma of the Central Nervous System: Strong Association With Unfavorable Chromosomal Abnormalities and Other High-Risk Disease Features","volume":"45","author":"Fassas","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/10428190802657751","article-title":"The Impact of Extramedullary Disease at Presentation on the Outcome of Myeloma","volume":"50","author":"Wu","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp329","article-title":"Incidence, Presenting Features and Outcome of Extramedullary Disease in Multiple Myeloma: A Longitudinal Study on 1003 Consecutive Patients","volume":"21","author":"Varettoni","year":"2010","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-3962","article-title":"The Tumor Microenvironment Innately Modulates Cancer Progression","volume":"79","author":"Hinshaw","year":"2019","journal-title":"Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020217","article-title":"The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression","volume":"13","author":"Garc\u00eda-Ortiz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.569017","article-title":"Molecular Immunotherapy: Promising Approach to Treat Metastatic Colorectal Cancer by Targeting Resistant Cancer Cells or Cancer Stem Cells","volume":"10","author":"Forster","year":"2020","journal-title":"Front Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v9.i10.169","article-title":"Tracing and Targeting Cancer Stem Cells: New Venture for Personalized Molecular Cancer Therapy","volume":"9","author":"Radpour","year":"2017","journal-title":"World J Stem Cells"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v10.i11.160","article-title":"Single-Cell Analysis of Tumors: Creating New Value for Molecular Biomarker Discovery of Cancer Stem Cells and Tumor-Infiltrating Immune Cells","volume":"10","author":"Radpour","year":"2018","journal-title":"World J Stem Cells"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.1.100","article-title":"In Vitro Behavior of Hematopoietic Progenitor Cells Under the Influence of Chemoattractants: Stromal Cell-Derived Factor-1, Steel Factor, and the Bone Marrow Environment","volume":"91","author":"Kim","year":"1998","journal-title":"Blood"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081793","article-title":"Role and Therapeutic Targeting of SDF-1\u03b1\/CXCR4 Axis in Multiple Myeloma","volume":"13","author":"Ito","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/stem.787","article-title":"Bone Marrow-Derived Mesenchymal Stromal Cells are Attracted by Multiple Myeloma Cell-Produced Chemokine CCL25 and Favor Myeloma Cell Growth In Vitro and In Vivo","volume":"30","author":"Xu","year":"2012","journal-title":"Stem Cells"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.02.034","article-title":"Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis Through Elevated SDF-1\/CXCL12 Secretion","volume":"121","author":"Orimo","year":"2005","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13050951","article-title":"The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients With Multiple Myeloma Treated With Bortezomib","volume":"13","author":"Robak","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.06.059","article-title":"CXCR4 Regulates Extra-Medullary Myeloma Through Epithelial-Mesenchymal-Transition-Like Transcriptional Activation","volume":"12","author":"Roccaro","year":"2015","journal-title":"Cell Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2013.148","article-title":"Reduced CXCR4 Expression is Associated With Extramedullary Disease in a Mouse Model Of Myeloma and Predicts Poor Survival in Multiple Myeloma Patients Treated With Bortezomib","volume":"27","author":"Stessman","year":"2013","journal-title":"Leukemia"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.04.020","article-title":"Unusual Myeloma Relapse After Thalidomide Therapy: The Dark Side of the Moon","volume":"33","author":"Balleari","year":"2009","journal-title":"Leukemia Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2009.01.036","article-title":"Extramedullary (EMP) Relapse in Unusual Locations in Multiple Myeloma: Is There An Association With Precedent Thalidomide Administration and a Correlation of Special Biological Features With Treatment and Outcome","volume":"33","author":"Katodritou","year":"2009","journal-title":"Leuk Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.2.346","article-title":"Chemokine Stromal Cell-Derived Factor-1alpha Modulates VLA-4 Integrin-Mediated Multiple Myeloma Cell Adhesion to CS-1\/Fibronectin and VCAM-1","volume":"97","author":"Sanz-Rodr\u00edguez","year":"2001","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.332","article-title":"In Vivo Adhesion of Malignant B Cells to Bone Marrow Microvasculature is Regulated by \u03b14\u03b21 Cytoplasmic-Binding Proteins","volume":"30","author":"Mart\u00ednez-Moreno","year":"2016","journal-title":"Leukemia"},{"key":"B32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41598-021-03748-0","article-title":"Ablation of VLA4 in Multiple Myeloma Cells Redirects Tumor Spread and Prolongs Survival","volume":"12","author":"Hathi","year":"2022","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2016.5","article-title":"Heparanase-Induced Shedding of Syndecan-1\/CD138 in Myeloma and Endothelial Cells Activates VEGFR2 and an Invasive Phenotype: Prevention by Novel Synstatins","volume":"5","author":"Jung","year":"2016","journal-title":"Oncogenesis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-007-9108-4","article-title":"Extravasation and Homing Mechanisms in Multiple Myeloma","volume":"25","author":"Vande Broek","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13387","article-title":"Adhesion Molecule Immunophenotype of Bone Marrow Multiple Myeloma Plasma Cells Impacts the Presence of Malignant Circulating Plasma Cells in Peripheral Blood","volume":"43","author":"Klimien\u0117","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"153567","DOI":"10.1016\/j.prp.2021.153567","article-title":"CD56 Expression in Multiple Myeloma: Correlation With Poor Prognostic Markers But No Effect on Outcome","volume":"225","author":"Koumpis","year":"2021","journal-title":"Pathol Res Pract"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03513.x","article-title":"Clinicopathological and Prognostic Characteristics of CD56-Negative Multiple Myeloma","volume":"117","author":"Sahara","year":"2002","journal-title":"Br J Haematol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402336","article-title":"CD44 Variant Isoforms are Involved in Plasma Cell Adhesion to Bone Marrow Stromal Cells","volume":"16","author":"Van Driel","year":"2002","journal-title":"Leukemia"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvs108","article-title":"The Impact of Aggrus\/podoplanin on Platelet Aggregation and Tumour Metastasis","volume":"152","author":"Fujita","year":"2012","journal-title":"J Biochem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1411082111","article-title":"Platelets Guide the Formation of Early Metastatic Niches","volume":"111","author":"Labelle","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2011.09.009","article-title":"Direct Signaling Between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis","volume":"20","author":"Labelle","year":"2011","journal-title":"Cancer Cell"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-2003","article-title":"Platelets Enhance Multiple Myeloma Progression via IL-1\u03b2 Upregulation","volume":"24","author":"Takagi","year":"2018","journal-title":"Clin Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-20-0164","article-title":"ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma Within the Bone Marrow Microenvironment","volume":"2","author":"Bianchi","year":"2021","journal-title":"Blood Cancer Discovery"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020216","article-title":"Signaling Pathway Mediating Myeloma Cell Growth and Survival","volume":"13","author":"Hideshima","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2174\/138920106778521569","article-title":"Recent Advances in the Treatment of Multiple Myeloma","volume":"7","author":"Yasui","year":"2006","journal-title":"Curr Pharm Biotechnol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0009-3","article-title":"An Early History of T Cell-Mediated Cytotoxicity","volume":"18","author":"Golstein","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00550","article-title":"The PD1:PD-L1\/2 Pathway From Discovery to Clinical Implementation","volume":"7","author":"Bardhan","year":"2016","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"12641","DOI":"10.1038\/s41598-020-69616-5","article-title":"PD-L1 Expression in Bone Marrow Plasma Cells as a Biomarker to Predict Multiple Myeloma Prognosis: Developing a Nomogram-Based Prognostic Model","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.663406","article-title":"Epigenetic Silencing of Immune-Checkpoint Receptors in Bone Marrow- Infiltrating T Cells in Acute Myeloid Leukemia","volume":"11","author":"Radpour","year":"2021","journal-title":"Front Oncol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.13033","article-title":"Increased Exhausted CD8(+) T Cells With Programmed Death-1, T-Cell Immunoglobulin and Mucin-Domain-Containing-3 Phenotype in Patients With Multiple Myeloma","volume":"14","author":"Tan","year":"2018","journal-title":"Asia Pac J Clin Oncol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15888","article-title":"Phase 1b Trial of Pembrolizumab Monotherapy for Relapsed\/Refractory Multiple Myeloma: KEYNOTE-013","volume":"186","author":"Ribrag","year":"2019","journal-title":"Br J Haematol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30110-3","article-title":"Pembrolizumab Plus Pomalidomide and Dexamethasone for Patients With Relapsed or Refractory Multiple Myeloma (KEYNOTE-183): A Randomised, Open-Label, Phase 3 Trial","volume":"6","author":"Mateos","year":"2019","journal-title":"Lancet Haematol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-623975","article-title":"Dendritic Cells Accumulate in the Bone Marrow of Myeloma Patients Where They Protect Tumor Plasma Cells From CD8+ T-Cell Killing","volume":"126","author":"Leone","year":"2015","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.3390\/cancers12123713","article-title":"Preclinical Rationale for Targeting the PD-1\/PD-L1 Axis in Combination With a CD38 Antibody in Multiple Myeloma and Other CD38-Positive Malignancies","volume":"12","author":"Verkleij","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.779319","article-title":"Single-Cell Transcriptomic Analysis Revealed a Critical Role of SPP1\/CD44-Mediated Crosstalk Between Macrophages and Cancer Cells in Glioma","volume":"9","author":"He","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-1148","article-title":"Myeloid-Derived Suppressive Cell Expansion Promotes Melanoma Growth and Autoimmunity by Inhibiting CD40\/IL27 Regulation in Macrophages","volume":"81","author":"Valencia","year":"2021","journal-title":"Cancer Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13205159","article-title":"Inflammatory Mediators and Gut Microbial Toxins Drive Colon Tumorigenesis by IL-23 Dependent Mechanism","volume":"13","author":"Panneerselvam","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2021.10.010","article-title":"Macrophage Peroxiredoxin 5 Deficiency Promotes Lung Cancer Progression via ROS-Dependent M2-Like Polarization","volume":"176","author":"Seong","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.1038\/s41467-020-20140-0","article-title":"Tumor Derived UBR5 Promotes Ovarian Cancer Growth and Metastasis Through Inducing Immunosuppressive Macrophages","volume":"11","author":"Song","year":"2020","journal-title":"Nat Commun"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005327","article-title":"Tissue-Resident Macrophages Promote Early Dissemination of Multiple Myeloma via IL-6 and Tnf\u03b1","volume":"5","author":"Akhmetzyanova","year":"2021","journal-title":"Blood Adv"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-013-9381-6","article-title":"Anti-Inflammatory M2, But Not Pro-Inflammatory M1 Macrophages Promote Angiogenesis In Vivo","author":"Jetten","year":"2014","journal-title":"Angiogenesis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"106709","DOI":"10.1016\/j.leukres.2021.106709","article-title":"Tumor-Associated Macrophages Modulate Angiogenesis and Tumor Growth in a Xenograft Mouse Model of Multiple Myeloma","volume":"110","author":"Sun","year":"2021","journal-title":"Leuk Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"6960","DOI":"10.1038\/s41467-021-26951-z","article-title":"Subclone-Specific Microenvironmental Impact and Drug Response in Refractory Multiple Myeloma Revealed by Single-Cell Transcriptomics","volume":"12","author":"Tirier","year":"2021","journal-title":"Nat Commun"},{"key":"B64","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41420-021-00432-0","article-title":"BMI1 Regulates Multiple Myeloma-Associated Macrophage\u2019s Pro-Myeloma Functions","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1002\/path.4860","article-title":"Tumour-Associated Macrophage-Mediated Survival of Myeloma Cells Through STAT3 Activation","volume":"241","author":"De Beule","year":"2017","journal-title":"J Pathol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.7150\/jca.30102","article-title":"High Numbers of CD163+ Tumor-Associated Macrophages Correlate With Poor Prognosis in Multiple Myeloma Patients Receiving Bortezomib-Based Regimens","volume":"10","author":"Wang","year":"2019","journal-title":"J Cancer"},{"key":"B67","doi-asserted-by":"publisher","first-page":"100253","DOI":"10.1016\/j.jbo.2019.100253","article-title":"The Role of CXCR4 in Multiple Myeloma: Cells\u2019 Journey From Bone Marrow to Beyond","volume":"17","author":"Ullah","year":"2019","journal-title":"J Bone Oncol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.141","article-title":"Anti-CD47 Antibodies Promote Phagocytosis and Inhibit the Growth of Human Myeloma Cells","volume":"26","author":"Kim","year":"2012","journal-title":"Leukemia"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4986","article-title":"Myeloma Cells Block RUNX2\/CBFA1 Activity in Human Bone Marrow Osteoblast Progenitors and Inhibit Osteoblast Formation and Differentiation","volume":"106","author":"Giuliani","year":"2005","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2010.06.016","article-title":"Osteoblast Function in Myeloma","volume":"48","author":"Roodman","year":"2011","journal-title":"Bone"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197411142912001","article-title":"Evidence for the Secretion of an Osteoclast Stimulating Factor in Myeloma","volume":"291","author":"Mundy","year":"1974","journal-title":"N Engl J Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.07980.x","article-title":"Myeloma Cell-Induced Disruption of Bone Remodelling Compartments Leads to Osteolytic Lesions and Generation of Osteoclast-Myeloma Hybrid Cells","volume":"148","author":"Andersen","year":"2010","journal-title":"Br J Haematol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-07-517136","article-title":"Osteoblastic Niche Supports the Growth of Quiescent Multiple Myeloma Cells","volume":"123","author":"Chen","year":"2014","journal-title":"Blood"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.09.146","article-title":"Novel Aspects of Osteoclast Activation and Osteoblast Inhibition in Myeloma Bone Disease","volume":"338","author":"Heider","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-01-0148","article-title":"Immunocytochemistry Reveals RANKL Expression of Myeloma Cells","volume":"99","author":"Sezer","year":"2002","journal-title":"Blood"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-016-0162-2","article-title":"Adipose, Bone, and Myeloma: Contributions From the Microenvironment","volume":"100","author":"McDonald","year":"2017","journal-title":"Calcif Tissue Int"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-12-3905","article-title":"Dual Effects of Macrophage Inflammatory Protein-1alpha on Osteolysis and Tumor Burden in the Murine 5TGM1 Model of Myeloma Bone Disease","volume":"102","author":"Oyajobi","year":"2003","journal-title":"Blood"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.44","article-title":"Bone Metastasis: The Importance of the Neighbourhood","volume":"16","author":"Croucher","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404228","article-title":"BAFF and APRIL as Osteoclast-Derived Survival Factors for Myeloma Cells: A Rationale for TACI-Fc Treatment in Patients With Multiple Myeloma","volume":"20","author":"Abe","year":"2006","journal-title":"Leukemia"},{"key":"B80","doi-asserted-by":"publisher","first-page":"8983","DOI":"10.1038\/ncomms9983","article-title":"Osteoclasts Control Reactivation of Dormant Myeloma Cells by Remodelling the Endosteal Niche","volume":"6","author":"Lawson","year":"2015","journal-title":"Nat Commun"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1703","article-title":"Bidirectional Notch Signaling and Osteocyte-Derived Factors in the Bone Marrow Microenvironment Promote Tumor Cell Proliferation and Bone Destruction in Multiple Myeloma","volume":"76","author":"Delgado-Calle","year":"2016","journal-title":"Cancer Res"},{"key":"B82","article-title":"Osteogenic Inhibition in Multiple Myeloma","volume":"15","author":"Habibi","year":"2013","journal-title":"Cell J"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13056","article-title":"A Phase IB Multicentre Dose-Determination Study of BHQ880 in Combination With Anti-Myeloma Therapy and Zoledronic Acid in Patients With Relapsed or Refractory Multiple Myeloma and Prior Skeletal-Related Events","volume":"167","author":"Iyer","year":"2014","journal-title":"Br J Haematol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-0284","article-title":"Runx2 Deficiency in Osteoblasts Promotes Myeloma Progression by Altering the Bone Microenvironment at New Bone Sites","volume":"80","author":"Xu","year":"2020","journal-title":"Cancer Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0519-4","article-title":"Dynamic CD138 Surface Expression Regulates Switch Between Myeloma Growth and Dissemination","volume":"34","author":"Akhmetzyanova","year":"2020","journal-title":"Leukemia"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2013.2134","article-title":"Hypoxia Reduces CD138 Expression and Induces an Immature and Stem Cell-Like Transcriptional Program in Myeloma Cells","volume":"43","author":"Kawano","year":"2013","journal-title":"Int J Oncol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-0115","article-title":"HIF-2\u03b1 Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12\/CXCR4 and CCR1","volume":"77","author":"Vandyke","year":"2017","journal-title":"Cancer Res"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1172\/JCI66517","article-title":"BM Mesenchymal Stromal Cell-Derived Exosomes Facilitate Multiple Myeloma Progression","volume":"123","author":"Roccaro","year":"2013","journal-title":"J Clin Invest"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133236","article-title":"Extracellular Vesicles Enhance Multiple Myeloma Metastatic Dissemination","volume":"20","author":"Colombo","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64887-0","article-title":"Shedding of the Matrix Metalloproteinases MMP-2, MMP-9, and MT1-MMP as Membrane Vesicle-Associated Components by Endothelial Cells","volume":"160","author":"Taraboletti","year":"2002","journal-title":"Am J Pathol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.1038\/s41598-017-05002-y","article-title":"Exosomes From Metastatic Cancer Cells Transfer Amoeboid Phenotype to non-Metastatic Cells and Increase Endothelial Permeability: Their Emerging Role in Tumor Heterogeneity","volume":"7","author":"Schillaci","year":"2017","journal-title":"Sci Rep"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2017.12.020","article-title":"Mechanisms Coupling Thrombin to Metastasis and Tumorigenesis","author":"Remiker","year":"2018","journal-title":"Thromb Res"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2017.09.001","article-title":"Chemotherapy Induces Secretion of Exosomes Loaded With Heparanase That Degrades Extracellular Matrix and Impacts Tumor and Host Cell Behavior","volume":"65","author":"Bandari","year":"2018","journal-title":"Matrix Biol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.941437\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T03:55:32Z","timestamp":1656647732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.941437\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":93,"alternative-id":["10.3389\/fonc.2022.941437"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.941437","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,1]]},"article-number":"941437"}}